Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Site-specific catalytic cleavage of RNA achieved with ribozyme analogue

Sep. 13, 1996

Dolastatin 10 mimic dolaphenine androstane

Sep. 13, 1996

Antiangiogenic eponemycin analogues

Sep. 13, 1996

Dual TNF production and PDE IV inhibitor from Pfizer

Sep. 13, 1996

A new class of selective COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

Antirhinovirus compounds from Lilly

Sep. 13, 1996

Antibacterial 2-pyridones, a novel class of DNA gyrase inhibitors

Sep. 13, 1996

Potential BPH therapy from Glaxo Wellcome

Sep. 6, 1996

5alpha-Reductase inhibitors for BPH

Sep. 6, 1996

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...